期刊文献+

辽宁住院高血压患者药物利用分析 被引量:3

Antihypertensive drug use among hypertensive inpatients in Liaoning province
原文传递
导出
摘要 目的了解三级甲等医院住院高血压患者降压药的药物利用情况,促进抗高血压药物的合理使用。方法自辽宁省两城市方便抽样选择4家三级甲等医院,随机选取2011年1月1日—2016年1月1日高血压住院患者8 000例,提取病历中抗高血压药物信息,分析抗高血压药物利用情况。结果抗高血压药物使用例次最多的为氨氯地平8.49%(2 055/24 192),用药频度最高的抗高血压药物是缬沙坦(31 391.85),DUI值最大的抗高血压药物是缬沙坦氨氯地平(1.63),DUI值最小的抗高血压药物是咪达普利(0.75),DUI值接近1.0的抗高血压药物分别是氯沙坦(0.98)、尼卡地平(0.99)、美托洛尔(1.01)、厄贝沙坦(1.02)、厄贝沙坦氢氯噻嗪(1.03)。结论辽宁两城市高血压住院患者抗高血压药物利用较合理。 Objective To examine antihypertensive drug use among hypertension patients hospitalized in hospitals of grade III class A in Liaoning province for the promotion of reasonable application of antihypertensive drugs.Methods Using convenient sampling we selected 4 hospitals of grade III class A in 2 cities of Liaoning province.Information on antihypertensive drug use were extracted from medical records of a total of 8 000 hypertension patients hospitalized in one of the 4 hospitals (2 000 patients for each hospital) between January 1,2011 and January 1,2016 and then analyzed statistically.Results The most frequently used antihypertensive drug was amlodipine (8.49%,2 055/24 192 case-times).For all the antihypertensive drugs utilized,the maximum defined daily doses (DDDs) was 31 391.85 for valsartan; the maximum drug utilization index was 1.63 for valsartan amlodipine; and the minimum drug utilization index was 0.75 for imidapril.The utilized antihypertensive drugs with the drug utilization index approximately to one were losartan (0.98),nicardipine (0.99),metoprolol (1.01),irbesartan (1.02),and irbesartan hydrochlorothiazide (1.03),respectively.Conclusion The utilization of antihypertensive drugs is rational for hypertension patients hospitalized in large hospitals in two cities of Liaoning province.
作者 高阿妮 王国锋 孙晓辉 吴锋 佟利剑 李丹 GAO A-ni WANG Guo-feng SUN Xiao-hui et al(Affiliated Zhongshan Hospital of Dalian University, Dalian, Liao- ning Province 116001, China)
出处 《中国公共卫生》 CAS CSCD 北大核心 2017年第3期404-406,共3页 Chinese Journal of Public Health
关键词 高血压 降压药物 药物利用评价 药物流行病 hypertension antihypertensive drug drug use evaluation pharmacoepidemiology
  • 相关文献

参考文献9

二级参考文献87

  • 1罗彩琴,贾绍斌,王义勇,丛广志,汪浩,刘静.宁夏高血压社区干预效果评价[J].宁夏医科大学学报,2012,34(3):237-240. 被引量:4
  • 2陈勇,濮欣,刘晓明,朱丽娟,张灵芝,何宝先.高血压病社区综合干预效果分析[J].中国慢性病预防与控制,2006,14(1):24-26. 被引量:42
  • 3蓝玉娟.高血压患者社区干预的效果评价.中国医药指南,2009,7(9):247-248.
  • 4国家食品药品监督管理局数据查询[EB/OL].(2010-05-08). http://www. SFDA. gov. cn/datasearch.
  • 5ICH. E12 : Principles for clinical evaluation of new antihypertensive drugs [ EB/OL ]. (2010 - 05 - 08 ). http ://www. ich. org/ cache/compo/475-272-1, html.
  • 6CUTLER JA, SORLIE PD, WOLZ M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988 - 1994 and 1999 - 2004 [ J ]. Hypertension, 2008, 52(5):818-827.
  • 7MACMAHON S, CHALMERS J, NEAL B,et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitns (the ADVANCE trial) : a randomised controlled trial[ J]. Lancet, 2007,370 ( 9590 ) :829 - 840.
  • 8MANN JF, SCHMIEDER RE, MCQUEEN M, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk(the ONTARGET study): a multicentre, randomised, double-blind, controlled trial [ J ]. Lancet, 2008,372 ( 9638 ) : 547 - 553.
  • 9MEURIN PP. The ASCOT trial: clarifying the role of ACE inhibition in the reduction of cardiovascular events in patients with hypertension[J]. Am J Cardiovasc Drugs, 2006,6(5) :327 -334.
  • 10JAMERSON K,WEBER MA,BAKRIS GL,et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients[ J]. N Engl J Med,2008,359 (23) :2417 - 2428.

共引文献82

同被引文献18

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部